BACKGROUND: Olfactory dysfunction is associated with Alzheimer's disease (AD), and already present at pre-dementia stage. OBJECTIVES: Based on the assumption that early neurodegeneration in AD is asymmetrical and that olfactory input is primarily processed in the ipsilateral hemisphere, we assessed whether unirhinal psychophysical and electrophysiological assessment of olfactory function can contribute to the diagnostic workup of mild cognitive impairment (MCI). METHODS: Olfactory function of 13 MCI patients with positive amyloid PET, 13 aged-matched controls (AC) with negative amyloid PET and 13 patients with post-infectious olfactory loss (OD) was assessed unirhinally using (1) psychophysical testing of olfactory detection, discrimination...
Background: Odor identification (OI) ability is a suggested early biomarker of Alzheimer’s disease. ...
Background: The objectives of this study were to explore the relationship between olfactory impairme...
BACKGROUND: Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem...
Introduction and Aim: Olfactory dysfunction is associated with Alzheimer’s disease (AD), and already...
Olfactory dysfunction constitutes one of the earliest signs of Alzheimer's disease (AD) and has been...
Olfactory dysfunction constitutes one of the earliest signs of Alzheimer’s disease (AD) and has been...
High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse p...
Olfactory impairment is present in up to 90% of patients with Alzheimer's disease (AD) and is presen...
OBJECTIVE: This study evaluated the predictive utility of olfactory identification deficits in patie...
© 2016 American Medical Association. IMPORTANCE To increase the opportunity to delay or prevent mild...
Abstract Background Alzheimer’s disease (AD) is the most common cause of dementia and early and accu...
Olfactory impairment is present in up to 90% of patients with Alzheimer's disease (AD) and is presen...
OBJECTIVES: Impaired olfaction may be a biomarker for early Lewy body disease, but its value in mild...
Abstract Introduction Alzheimer’s disease (AD) is a debilitating neurodegenerative disease that curr...
Background: Olfactory dysfunction is present since the earliest stage of Alzheimer's disease (AD). ...
Background: Odor identification (OI) ability is a suggested early biomarker of Alzheimer’s disease. ...
Background: The objectives of this study were to explore the relationship between olfactory impairme...
BACKGROUND: Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem...
Introduction and Aim: Olfactory dysfunction is associated with Alzheimer’s disease (AD), and already...
Olfactory dysfunction constitutes one of the earliest signs of Alzheimer's disease (AD) and has been...
Olfactory dysfunction constitutes one of the earliest signs of Alzheimer’s disease (AD) and has been...
High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse p...
Olfactory impairment is present in up to 90% of patients with Alzheimer's disease (AD) and is presen...
OBJECTIVE: This study evaluated the predictive utility of olfactory identification deficits in patie...
© 2016 American Medical Association. IMPORTANCE To increase the opportunity to delay or prevent mild...
Abstract Background Alzheimer’s disease (AD) is the most common cause of dementia and early and accu...
Olfactory impairment is present in up to 90% of patients with Alzheimer's disease (AD) and is presen...
OBJECTIVES: Impaired olfaction may be a biomarker for early Lewy body disease, but its value in mild...
Abstract Introduction Alzheimer’s disease (AD) is a debilitating neurodegenerative disease that curr...
Background: Olfactory dysfunction is present since the earliest stage of Alzheimer's disease (AD). ...
Background: Odor identification (OI) ability is a suggested early biomarker of Alzheimer’s disease. ...
Background: The objectives of this study were to explore the relationship between olfactory impairme...
BACKGROUND: Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem...